Cargando…
Treatment of experimental colitis in mice with LMP-420, an inhibitor of TNF transcription
BACKGROUND: LMP-420 is a boronic acid-containing purine nucleoside analogue that transcriptionally inhibits TNF production but is non-cytotoxic to TNF-producing cells. METHODS: This study investigated the efficacy of LMP-420 as an anti-inflammatory agent in acute and chronic colitis induced by oral...
Autores principales: | Hale, Laura P, Cianciolo, George |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2322983/ https://www.ncbi.nlm.nih.gov/pubmed/18331642 http://dx.doi.org/10.1186/1476-9255-5-4 |
Ejemplares similares
-
LMP-420, a small-molecule inhibitor of TNF-alpha, reduces replication of HIV-1 and Mycobacterium tuberculosis in human cells
por: Haraguchi, Soichi, et al.
Publicado: (2006) -
Prevention of colitis-associated cancer by selective targeting of immunoproteasome subunit LMP7
por: Vachharajani, Niyati, et al.
Publicado: (2017) -
The Selective Phosphodiesterase 4 Inhibitor Roflumilast and Phosphodiesterase 3/4 Inhibitor Pumafentrine Reduce Clinical Score and TNF Expression in Experimental Colitis in Mice
por: Rieder, Florian, et al.
Publicado: (2013) -
Synthesis and Biological Evaluation
of New Carbohydrate-Substituted
Indenoisoquinoline Topoisomerase I Inhibitors and Improved Syntheses
of the Experimental Anticancer Agents Indotecan (LMP400) and Indimitecan
(LMP776)
por: Beck, Daniel E., et al.
Publicado: (2014) -
Effects of anti-TNF-α in experimental diversion colitis
por: Buanaim, Ronaldo Parisi, et al.
Publicado: (2019)